Inhibitory Effects of New Mercapto Xanthine Derivatives in Human mcf7 and k562 Cancer Cell Lines
作者:Haider N. Sultani、Rasha A. Ghazal、Alaa M. Hayallah、Loay K. Abdulrahman、Khaled Abu-Hammour、Shatha AbuHammad、Mutasem O. Taha、Malek A. Zihlif
DOI:10.1002/jhet.2602
日期:2017.1
7‐tetrahydro‐1H‐purin‐8‐yl)thio]‐N‐ substituted arylacetamides were synthesized. The antitumor activity of these purine based compounds were evaluated on breast cancer (MCF7) and leukemic cancer (K562) cell lines via cell viability assay utilizing the tetrazolium dye 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT). These results were substantiated using computer docking experiments (LigandFit
一系列新的2-甲基-2-[((1,3-二乙基-2,6-二氧代-2-3,3,6,7-四氢-1 H-嘌呤-8-基)硫基] N取代的芳基乙酰胺被合成。这些嘌呤类化合物对乳腺癌(MCF7)和白血病(K562)细胞系的抗肿瘤活性通过四唑鎓染料3-(4,5-二甲基噻唑-2-基)-2-5-5-的细胞活力测定进行了评估。溴化二苯四唑(MTT)。使用计算机对接实验(LigandFit对接引擎和PMF评分功能)证实了这些结果,该实验预测这些新化合物的抗肿瘤活性可能归因于其有效结合和阻断致癌酪氨酸激酶(特别是bcr / abl)的能力。